Ligand validation:3FHI

ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER

ANP is a Ligand Of Interest in 3FHI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3FHI_ANP_A_400	59%	6%	0.172	0.956	2.87	2.12	8	11	0	0	100%	1
4DFX_ANP_E_402	100%	32%	0.036	0.989	1.35	1.35	4	2	1	0	100%	1
4DG3_ANP_E_401	100%	25%	0.042	0.988	1.58	1.45	5	3	0	0	100%	1
4HPU_ANP_I_600	99%	29%	0.043	0.982	1.38	1.48	6	4	0	0	100%	0.55
4DH7_ANP_A_403	98%	17%	0.05	0.975	2.19	1.45	10	4	0	0	100%	1
4DH8_ANP_A_403	92%	17%	0.088	0.978	2.19	1.44	10	4	0	0	100%	1
8PS7_ANP_A_704	100%	43%	0.023	0.994	1.15	1.05	4	2	0	0	100%	1
9AVR_ANP_A_501	100%	36%	0.034	0.991	1.05	1.46	2	5	2	0	100%	1
4BRA_ANP_A_1394	100%	12%	0.037	0.993	2.3	1.8	10	6	3	0	100%	1
4BRD_ANP_B_1396	100%	16%	0.041	0.994	1.66	2.04	4	10	1	0	100%	1
3CJA_ANP_A_501	100%	13%	0.037	0.988	1.9	2.1	8	7	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.